We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Avingtrans Plc | AVG | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 415.00 | 08:00:24 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 415.00 | 415.00 | 420.00 | 415.00 |
| Industry Sector |
|---|
| INDUSTRIAL ENGINEERING |
| Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
|---|---|---|---|---|---|---|
| 28/02/2024 | Interim | GBP | 0.018 | 23/05/2024 | 24/05/2024 | 21/06/2024 |
| 27/09/2023 | Final | GBP | 0.028 | 26/10/2023 | 27/10/2023 | 08/12/2023 |
| 22/02/2023 | Interim | GBP | 0.017 | 11/05/2023 | 12/05/2023 | 16/06/2023 |
| 28/09/2022 | Final | GBP | 0.026 | 27/10/2022 | 28/10/2022 | 09/12/2022 |
| 23/02/2022 | Interim | GBP | 0.016 | 12/05/2022 | 13/05/2022 | 17/06/2022 |
| 29/09/2021 | Final | GBP | 0.04 | 28/10/2021 | 29/10/2021 | 10/12/2021 |
| 18/09/2019 | Final | GBP | 0.024 | 24/10/2019 | 25/10/2019 | 06/12/2019 |
| 27/02/2019 | Interim | GBP | 0.014 | 23/05/2019 | 24/05/2019 | 14/06/2019 |
| Top Posts |
|---|
Posted at 28/2/2024 11:41 by earwacks Yes they were that good. The acquisitions cost them 13 million last year. Someone on Stockopedia said about Adaptix not being able to attract any other offers. Firstly Avg already had 10 percent of the business and secondly they invited them to find a better offer. This is what Avg are renowned for, taking over businesses that have potential but cash strapped, building the business up to profitability and selling it on. It doesn’t happen over night. The nuclear waste business is booming and still no competitors in a sector they can barely service on their own . The cancelled rail works has not affected them at all and think there will be additional work there. The applications and potential for Adaptix and Magnetica are not even fully realised yet, way beyond just medical. I agree health authorities are under pressure, but actually these products could well help reduce workloads as time saving potential is huge. On the veterinary side , there will be no such problem as pet spend ever increases. Their markets are mostly in areas that are not cyclical, they are essential. Of course their is capital required in these projects. That is the mainstay of their business. Buy companies cheap, invest and sell |
Posted at 28/2/2024 08:21 by alter ego when is the dividend to be paid - couldn't see it |
Posted at 28/2/2024 07:22 by brummy_git Another encouraging & 'in line' set of numbers and guidance from niche engineer Avingtrans today.All the details & commentary here |
Posted at 11/2/2024 20:43 by cerrito I have been catching up on these given the recent price drop to see if I should buy more but will keep my hands in my pockets.That said, uncomfortable being out of these as say the sale of Booth would give them a comfortable rerating although we will need to show continued patience ref monetizing the HT Luton site. I agree that a good deal of potential in Medical but even with the current shareprice drop,basic eps of last year's continuing and discontining earnings is approx 23x. Of course with both Cavendish and Singer forecasting an adjusted eps of 2.8p for this current FY the PE even at current prices becomes extreme. I note Cavendish have a TP at 495p and for Singer it is 510p. I am comfortable we will get to these prices in 2025. I also note the issue of high receivables, the 1.2 PC approx dividend yield and no share buybacks in the offing and their lack of interest in shareholders like me. . |
Posted at 09/2/2024 20:57 by cockerhoop Those forecasts are ballpark as the company now owns Adaptix and a larger slice of Magnetica which will both be loss making this year as AVG invests towards commercialisation of their 3d x-ray and MRI products.I accept the UK market is probably not mature enough to look beyond the PE ratio but it really isn't the best way to value companies like AVG. |
Posted at 20/1/2024 09:09 by alter ego this is what I see |
Posted at 18/1/2024 07:21 by brummy_git More positive news from specialist engineering & medical devices firm Avingtrans today.All the details here. |
Posted at 09/11/2023 11:24 by cockerhoop The problem AVG may encounter regards valuation is that on the surface the financial forecasts have gone backwards because of the increased investment required in Magnetica and Adaptix. So to anyone valuing the business on a PE basis (incorrect way in my view) it looks much more expensive than previously. (adj eps reduced from 21.9p to 2.8p).I'd suggest it's more sensible to value on a sum of parts valuation of the subsidiaries. |
Posted at 09/11/2023 07:14 by steve3sandal Thanks for your support and comments here chaps. Not bought back yet. We all seem fairly happy that operationally the company is going up so it’s odd the share price is travelling down. Perhaps AVG is just a victim of the general market selling and drift in UK small caps as MMs try to find buyers lower down. As ever will SPs turn without notice and I guess the AVG share price is just news driven. Still here but not yet if you know what I mean. GLA. |
Posted at 11/10/2023 14:59 by steve3sandal Thank you both. I was hoping they weren’t encasing the whole plant. I’m largely hoping to buyback under £4 as I’m cheap, just have to be patient and keep my fingers crossed. The portable MRI scanner opportunity they have built looks very interesting and very AVG. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
